2008ÄêÉϺ£½»´ó½âÆÊ¿¼²©ÕæÌâ ,HQaS9vBQ
Ãû´Ê½âÊÍ: bJE$
>
¾±¶¯Âöñ¼,»áÒõ,ÑÊÏ¿,·Î¶Î,¸ÎÍ⵨µÀϵͳ,Ó²ÄÔĤñ¼ ;tF7GjEp
ÎÊ´ð: <v)Ai;l,
Þ²ÂöÑ»·,Ï¥¹Ø½Ú×é³ÉÔ˶¯·½Ê½¿ØÖƼ¡Èâ,ëè¹Ç¾±¹ÇÕÛÒ×ËðÉËʲôÉñ¾³öÏÖʲô֢״,Ðص¼¹Ü×ßÐÐ;¾¶¡£À»Î²µÄλÖã¬Ìå±í±êÖ¾£¬ÊÖÊõ¹ý³ÌÖÐÈçºÎÑ°ÕÒ£¿Èé·¿µÄÁÜ°Í»ØÁ÷¡£ CL$mK5u
08Ä껪ÖпƼ¼´óѧÉñ¾²¡Ñ§ V0h
8HyK;+ZkVd
Ãû´Ê½âÊÍ£º &<P!o_+eb
f`jRLo*L
1. parinand syndrome ?N|B, F
f}'E|:Z 7k
2. migraine equivalents <eq93
!.'@3-w]
3. Glossopharyngeal neuralgia 5[|MO.CB$
? 1g<] ?
4. Queckenstedt test N(]>(S
o
,zLi{a6
5. Éñ¾Ê§Óà ;q&>cnLDR
(,E.1j]ji
6. ¹¹ÒôÕÏ° he/UvMu
}cll? 2
7. ¾±ÄÚ¶¯ÂöµÁѪ×ÛºÏÖ¢ Ve&(izI
h
g|PVOY+|^
8. µøµ¹·¢×÷ xOjCF&W
MdWT[
¶þ¡¢¼ò´ð£º qPpC )6-Q
IiACr@[?e
1. ºÎΪÄÑÖÎÐÔñ²ðÆäΣÏÕÒòËØÓÐÄÄÈçºÎ´¦Àí£¿ $+sNjwv^F
ejwFQ'wTx
2. ¼¹Ëè´«µ¼ÊøËðº¦ÁÙ´²±íÏÖ? !V.'~xj
f4zd(J
3. ÈçºÎ¼ø±ðAD£¬VD£¿ Pb.-Z@
(i7]N[
4. ÂÄÚ¶¯ÂöÁö¿É²úÉúÄÇЩ֢״£¿ C CX\
"-C
Ku_`F2Q
5. ¼ø±ðLambert-Eaton syndromeºÍÖØÖ¢¼¡ÎÞÁ¦¡£ _EOQ*K#=Ct
@7%nMTZ@&v
6. ÄÔ¼¹Òº³£¹æ¼°Éú»¯¼ì²éÏîÄ¿¼°ÒâÒå¡£ NrTQ}_3)
'?_;s9)
08Ä껪ÖпƼ¼´óѧÉñ¾½âÆÊѧ jd=k[Yqr
\{n]&IjA
Ò»¡¢Ãû´Ê½âÊÍ£º LI?rz<H!D
MZE8Cvq0
1. Éñ¾½Ú2. Íø×´½á¹¹3. Í»´¥4. ÃæÉñ¾Çð5. Íâ²àÇðϵ6. ÄÚÄÒ7. »ùµ×ºË8. Willis»· q
[l},nw
K!k,]90Ko
¶þ¡¢¼ò´ðÌ⣺ ?G1-X~Z8
lx~!FLn
1. ÊÖµÄÉñ¾Ö§Åä W z3y+I/&
L!DP*XDp
2. Í·Ã沿¸±½»¸ÐÉñ¾½ÚµÄÃû³Æ¡¢Î»Öü°ÏËάÁªÏµ kVQKP U
$\$5::}r
3. ±³²àÇðÄÔÌØÒìÐÔͶÉäºËÍŵĹ¹³É¡¢ÏËάÁªÏµ¡¢¹¦ÄÜ @Wy>4B^
:=^JHE{
4. ¼òÊöÊÓ¾õ´«µ¼Í¨Â·¼°Ò»²àÊÇÉñ¾ÊÜËðÖ¢×´¼°ÔÒò KQ xKU?b1
gec<5Ewg
5. º£Ãàñ¼µÄλÖü°´©¾½á¹¹ Q,Hw@
w<1
ɽ¶«´óѧ2008²©Ê¿²¡ÀíÉúÀíÊÔÌ⣨רҵ»ù´¡£©£¨¼ÇÒä°æ£© x9~d_>'A
1 ϸ°ûÐźÅתµ¼Òì³£µÄÔÒò BM1uZJ0
2 ºôÎüÐÔËáÖж¾µÄÔÒòºÍ¶Ô»úÌåµÄÓ°Ïì y:D|U!o2V
3 Ë®Öж¾µÄÔÒòºÍ¶Ô»úÌåµÄÓ°Ïì (J][(=s;a
4 µÍÕÅÐÔȱÑõµÄÔÒòºÍѪÑõ±ä»¯Ìصã <Jo_f&&{
5 ¸Æ³¬ÔØÔÚÐļ¡ÔÙ¹à×¢ËðÉËÖеÄ×÷Óà "kz``6C
6 ÐÄË¥ÐË·Ü£ÊÕËõżÁª»úÖÆ kp[+Iun?
7 °©»ùÒòÖ°©µÄ»úÖÆ ykxjT@[
8 DICµÄÁÙ´²±íÏÖ¼°»úÖÆ ?z171X0
9²¡Àý·ÖÎö ´óÌåÊÇ Ò»Ãû45ËêÅ®ÐÔ£¬Ïø´22Ä꣬½üÒ»ÔÂÀ´ºôÎüÀ§ÄÑ£¬³öÏÖÇéÐ÷²»ÎÈ£¬Í·ÔεÈÖ¢×´£¬ÑªÆøʾPCO2 70¡¢ PCO2 50,·ÖÎöÆäÖеIJ¡ÀíÏÖÏó»úÖÆ !t{3IE
10 ²¡Àý·ÖÎö ´óÌåÊÇ µ¨ÄÒÑײ¡ÈËÓ¦ÓÃÇì´óùËØ4Öܺó³öÏÖÅ»ÐÄŻ͡¢ÄòÉÙ¡¢Ê³Óû½µµÍµÈ²»ÊÊ£¬ÑªÆøʾPCO2 28¡¢PH 7.35£¨£¿£©¡¢Ñª¼Ø6.5 BE -15,SB12 £¨Êý¾Ý£¿£©£¬ÎÊ·¢ÉúÁËʲô²¡ÀíÉúÀíÇé¿ö£¬²¢½âÊÍÈçºÎ·¢ÉúµÄ //\ORJd
"ZNiTND
ɽ¶«´óѧ2008Ä꿼²©ÃâÒßÌâ(¼ÇÒä°æ) $985q@pV0
Ja|! fT
Ò»Ãû´Ê½âÊÍ(ÔÌâÈ«Ó¢Óï) IR?ICXmtx
FCM,Microassay,IgSF,PAMP,HLA,KLR,³¬¿¹Ô,ÃâÒߺöÊÓ,µ÷½ÚÐÔTϸ°û,»¹ÓÐÒ»¸öÍüÁË. +y>D3
I
¶þ¼ò´ð:1ʲôÊÇÒßÃç?ÆäÖÖÀ༰Ìصã Z+=W gEu1
2,IL-2ÔÚTϸ°û»î»¯ÖеÄ×÷Óà D!ToCVo
s
3Tϸ°ûÐźŴ«µ¼¹ý³Ì C+cSy'VIK!
4Bϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óà kV(}45i]s
5¿¹ÌåÇ׺ÍÁ¦³ÉÊìµÄ¹ý³Ì¼°»úÖÆ `)&-;CMY
6Á´Çò¾ú¸ÐȾºóµÃÉöСÇòÉöÑ×µÄÃâÒßËðÉË»úÖÆ ync2X{
9D
7ͬÖÖÒìÐÍ¿¹ÔµÄʶ±ð»úÖÆ `ux
U
H#
8CR1,CR2ÔÚÃâÒßÖеÄ×÷Óà 4T`u?T]
ÈýÂÛÊö:½áºÏÄã˶ʿ½×¶ÎµÄ¿ÎÌâ,Çë̸̸²©Ê¿½×¶ÎµÄ³õ²½Ñо¿·½Ïò Xlp u_H|
_y#t[|}w
"~9 !o"
29
L~SMf
2008Äê×îÐÂкÍÒ½¿Æ´óѧ²©Ê¿ÉúÈëѧרҵ·Ö×ÓÉúÎïѧ¿¼ÊÔÊÔÌâ cXFNX<
µÚÒ»²¿·Ö£ºÌî¿Õ &7!&]kA+
·èÅ£²¡µÄÖ²¡ÔÒò r;t0+aLc*
ʲôÊÇÔ²¡¶¾ DmM<Kkg.J
SDÐòÁÐ FylL7n
ÐźÅëÄʶ±ðÐòÁеÄ×é³É-----²¿·ÖºÍ-----²¿·Ö 'xm _oGWE
ÈéÌDzÙ×Ý×ӵĵ÷¿ØÐòÁСª¡ª¡ª¡ª¡ª¡ª ¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª ¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª 8 qt,sU
µÚ¶þ²¿·Ö£º´óÌ⣬2µÀ TggM/@k
1.¸øÁËÒ»¶ÎÐòÁÐÒªÇóÉæ¼°ºÏÊʵÄÒýÎÀ©Ôö³ö¸ÄÐòÁУ¬£¨¿¼µãΪÒýÎïÉè¼ÆÔÔò£© SEq_37
2.¸øÁËÒ»¸öÖÊÁ£ÐòÁУ¬ºÍÒ»¶Î´ý²åÈëµÄ»ùÒò×éDNAƬ¶Î£¬È»ºóøÇкóµçÓ¾£¬Ã¸ÇкóµçÓ¾£¬Èý¸öÓ¾µÀÓÐÈýÖÖ²»Í¬µÄÌõ´ø£¬·ÖÎöÆä²úÉúÇé¿ö£¨¿¼µãΪ¿Ë¡²¿·Ö£© bX:Y5o49
µÚÈý²¿·Ö£º ~C6
d5\
1.×ÏÍâÏß¹ý¶ÈÕÕÉäºóÈÝÒ×Òý·¢Æ¤·ô°©£¬Õý³£»úÌåͨ¹ýºÎÖÖ»úÖÆÐÞ¸´
Cb7f-Eag
2.½éÉܽÍĸ˫ÔÓ½»µÄÔÀíºÍÓ¦Óà K4YpE}
]u
3.¾ÙÀý˵Ã÷СRNAÔÚ·¢ÓýÖеÄ×÷ÓúÍÒâÒå XMd-r8yYr
3. ʲôÊÇת¼ºó¼Ó¹¤£¿Ä¿Ç°ÈÏΪÕâÒ»ÌᷨǷÍ×£¬ÎªÊ²Ã´£¿ Fd":\7p
4. ÈËÀà»ùÒò×éµ±ÖдæÔÚÐí¶à·Ç±àÂëÐòÁУ¬Èçת×ù×ÓºÍÄÚº¬×Ó£¬£¨1£©ÇëÎÊÕâЩ·Ç±àÂëÐòÁÐÊÇûÓмÛÖµµÄÀ¬»øÂð£¿ÎªÊ²Ã´£¿£¨2£© ½üÄêÀ´£¬Ð¡·Ö×ÓRNAµÄÑо¿Óë±í¹ÛÒÅ´«Ñ§½øչѸËÙ£¬ÊÇ·ñ±íÃ÷ÖÐÐÄ·¨ÔòÒѾ¹ýʱ£¬ÒѾ±»ÐµÄÀíÂÛÈ¡´ú£¿ $-[V)]h
&[f.;1+C
½»´óϸ°ûÉúÎïѧ2008Ä꿼²©ÊÔ¾í $NC1>83
&u( eu'Q3
10¸öÃû×Ö½âÊÍ oA%8k51>~K
SiRNA {O9CYP:
transcription factor >KmOTM<{
checkpionts 2`tdH|Z`
iPS cells @r]wZ~@
ĤÊÜÌå v=zqj}T
heterochromatin fNNkc[YTZI
PÐÍÔËÊäATPø =T
;>$&qs
µ°°×ÖÊ·ÖÑ¡ ^AkVmsv;;
΢¹ÜÏà¹Øµ°°×ÖÊ r!N)pt<g
integrin ;UTT>j
3o&PVU?Q
ÎÊ´ðÌ⣺ :Fz;nG-G
ºó»ùÒò×éʱ´úµ°°×ÖÊÑо¿µÄ¼¼Êõ£¬²ßÂÔ¡£ eR PmN
Éú³¤Òò×ÓÓëάAÑÜÉúÎïµÄÐźÅתµ¼ ~G|un}g=
2006¹ØÓÚÈã±´¶û½±Ð´Ò»¸öÆÀÂÛ qP{S!Z(
WPi^;c8
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2008ÐÄÄÚÊÔÌâ ?K%&N99c!
=+9.X8SP
µÚÒ»²¿·Ö ´óÄÚ¿Æ£¨40·Ö£© 4A6D>ChB'E
Ãû´Ê½âÊÍ X~ |P
´úл×ÛºÏÕ÷ °¢Ë¹¶þÊÏ×ÛºÏÕ÷ synscope ]L#6'|W
Liddle's×ÛºÏÕ÷ ³¦Ò×¼¤ÈÇ×ÛºÏÕ÷
T\ZWKx*#
ÎÊ´ðÌâ W`_pjld
ÐðÊöIÐͺÍIIÐͺôÎüË¥½ßµÄÁÙ´²Õï¶ÏºÍÖÎÁƵÄÉÏÇø±ð NBHS
DICµÄ²¡Òò¡¢Õï¶ÏºÍÖÎÁÆ 7OY<*ny
SQ!
wq
µÚ¶þ²¿·Ö רҵ£¨ÐÄÄÚ£© [~03Z[_"/
ÇëÐðÊö½ü10ÄêÀ´ÔÚÂýÐÔ×óÐÄË¥ÈÏʶ¡¢Õï¶Ï¼°ÖÎÁÆ·½ÃæµÄ×îнøÕ¹¡£ #U45;idp
·Î¶¯ÂöѪ˨²¡Òò¡¢¼ø±ðÕï¶ÏºÍÖÎÁÆ¡£ v$c*3H.seM
55ËêµÄÑ£Ôλ¼Õß¼ø±ðÕï¶ÏÒªµã 4Kjrk7GAx
»ºÂýÐÔÐÄÂÉʧ³£µÄ»¼Õß°éºÚÃÉ¡¢Ñ£ÔÎÈçºÎÑ¡ÔñÐÄÔàÆð²«Æ÷ !T;*F%G9
~>u]ow=
»ª¿Æ´óͬ¼ÃҽѧԺ¿¼²©×ÜÂÛ£«ÆÕÍâÊÔÌâ»ØÒä pwo5Ij,~q
V
;Kzh$^rk
×ÜÂÛ£º ^2Sa_.
1. ÀíÏëÊÖÊõÇпÚÓ¦¾ß±¸µÄÌõ¼þ NX7(;02
2.ÉöÌæ´úÁÆ·¨Ó¦´ïµ½µÄÖ¸±ê [<SM*fQ>t
3.DICµÄÁÙ´²±íÏÖ @V{s'V
4.´´ÉËÖÎÓúµÄ·ÖÆÚ¡¢´¦ÀíÔÔò H.`>t
5.ÀíÏëµÄÖ×Áö±êÖ¾ÎïÓ¦¾ß±¸µÄÌصã :N03$Tvl
רҵ£º Sh'>5z2
1.ÔçÆÚθ°©¶¨Òå¡¢ÖÎÁÆ z
d
9Gi5&
2.ÈéÏÙ°©ÊÖÊõ·½Ê½ %-ih$ZY
3.µ¨µÀÓ°Ïñѧ¼ì²éÓÐÄÄЩ¡¢¼°ÁÙ´²ÒâÒå -L e:%q2
4.¸Î°©²¡Àí·ÖÐÍ£¬¸ùÖÎÐÔÊÖÊõµÄÖ¸Õ÷ SN2X{Q|*
5.¸ÎÇ°ÐÔÃÅÂö¸ßѹµÄÔÒò¼°ÁÙ´²±íÏÖ Z-(#}(HD
6.ÒÈÏÙÑ×·ÖÐͼ°ÑÏÖس̶ȵÄÆÀ¹À